EMAIL THIS PAGE TO A FRIEND

Analytical and bioanalytical chemistry

Evaluation of detection sensitivity in comprehensive two-dimensional liquid chromatography separations of an active pharmaceutical ingredient and its degradants.


PMID 25064601

Abstract

In this paper, we describe the findings of a study aimed at assessing the detection sensitivity of comprehensive two-dimensional high-performance liquid chromatography (LCxLC) separation of a degraded active pharmaceutical ingredient (API) with UV absorption as the detection technique. Specifically, we have examined the impact of the volume and solvent composition (referred to as "interface conditions") of fractions of first-dimension column effluent transferred to the second dimension for further separation on the ability to resolve and detect low-abundance compounds. Historically, LCxLC has been perceived as being inferior to 1D-LC from the point of view of detection sensitivity. In this work, we demonstrate that LCxLC is sufficiently sensitive to be useful in the pharmaceutical context where in general impurities present at 0.05xa0% (relative to the API concentration) should be quantified. Moreover, we find that this level of sensitivity is only attained under certain conditions: dilution of the first column effluent with weak solvent (water in this case) prior to injection into the second-dimension column is very beneficial because it promotes focusing of the analyte band in the second column, thereby improving the detection sensitivity of the LCxLC system; and, quantitation limits are also a strong function of peak location in the second-dimension separation window, where baseline disturbances near the dead time of the second column can limit reliable detection of low-abundance compounds.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

284785
(S)-(+)-6-Methoxy-α-methyl-2-naphthaleneacetic acid, 98%
C14H14O3
45983
Acetonitrile, analytical standard
C2H3N
PHR1551
Acetonitrile, Pharmaceutical Secondary Standard; Certified Reference Material
C2H3N
00712
Acetonitrile solution, ~20% in H2O, for protein sequence analysis
C2H3N
17784
Apiin, ≥97.0% (HPLC)
C26H28O14
16350
Bromobenzene, ≥99.5% (GC)
C6H5Br
B57702
Bromobenzene, ReagentPlus®, 99%
C6H5Br
19600
Butylbenzene, analytical standard
C10H14
B90203
Butylbenzene, ≥99%
C10H14
47322
Butylbenzene, analytical standard
C10H14
N8280
Naproxen, meets USP testing specifications
C14H14O3
46482
Naproxen, VETRANAL, analytical standard
C14H14O3
PHR1040
Naproxen, Pharmaceutical Secondary Standard; Certified Reference Material
C14H14O3
N0250000
Naproxen, European Pharmacopoeia (EP) Reference Standard
C14H14O3
1457301
Naproxen, United States Pharmacopeia (USP) Reference Standard
C14H14O3
311421
Perchloric acid, 70%, 99.999% trace metals basis
HClO4
244252
Perchloric acid, ACS reagent, 70%
HClO4
311413
Perchloric acid, ACS reagent, 60%
HClO4
77234
Perchloric acid, puriss. p.a., ACS reagent, packed in coated, shock- and leak-protected glass bottle, ≥60% (T)
HClO4
77228
Perchloric acid, puriss. p.a., ACS reagent, 70% (Hg ≤0.0000005%), packed in coated, shock- and leak-protected glass bottle, ≥69% (T)
HClO4
30755
Perchloric acid, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 70.0-72.0%
HClO4
50439
Perchloric acid concentrate, 0.01 M HClO4 in water (0.01N), eluent concentrate for IC
HClO4
PHR1320
Residual Solvent - Acetonitrile, Pharmaceutical Secondary Standard; Certified Reference Material
C2H3N
1601340
Residual Solvent Class 2 - Acetonitrile, United States Pharmacopeia (USP) Reference Standard
C2H3N
442495
Bromobenzene, analytical standard
C6H5Br